Concepedia
Statistics
Publications
7
Citations
290
H-Index
Active since
1982
Affiliations
University of Colorado Health(Current)
Glasgow Victoria Infirmary
Aberdeen Royal Infirmary
University of Colorado Cancer Center
University of Colorado Denver
K. Beard is an author at University of Colorado Health specializing in pharmacology, medicine, and colorectal cancer.
Publications per year
1982–2007
Sulindac metabolites induce caspase- and proteasome-dependent degradation of beta-catenin protein in human colon cancer cells.
Pamela L. Rice, Jennifer Kelloff, Holly Sullivan et al. · PubMed · 2003 · 101 citations
Medicine, Oncology, Pharmacology +14
Point prevalence survey of antibiotic use in Scottish hospitals utilising the Glasgow Antimicrobial Audit Tool (GAAT)
R.A. Seaton, Dilip Nathwani, Paul Burton et al. · International Journal of Antimicrobial Agents · 2007 · 71 citations
Pharmacy, Infectious Diseases, Antimicrobial Pharmacotherapy +16
Inhibition of Extracellular-signal Regulated Kinases 1/2 Is Required for Apoptosis of Human Colon Cancer Cells <b> <i>In vitro</i> </b> by Sulindac Metabolites
Pamela L. Rice, K. Beard, Linda J Driggers et al. · Cancer Research · 2004 · 39 citations · Full text
Medicine, Oncology, Pharmacology +15
Sulindac sulfide inhibits epidermal growth factor-induced phosphorylation of extracellular-regulated kinase 1/2 and Bad in human colon cancer cells.
Pamela L. Rice, Michele N. Washington, Shea Schleman et al. · PubMed · 2003 · 35 citations
Sulindac independently modulates extracellular signal–regulated kinase 1/2 and cyclic GMP–dependent protein kinase signaling pathways
Pamela L. Rice, Stevany L. Peters, K. Beard et al. · Molecular Cancer Therapeutics · 2006 · 20 citations · Full text
Medicine, Oncology, Pharmacology +16
1–5 of 7